The purpose of this work was to evaluate the suitability of recent US Food and Drug Administration (US-FDA)-approved and marketed oral liquid, powder, or granule products …
S Vugigi - African Journal of Pharmacy and Alternative …, 2023 - journals.mjmbiolabs.co.ke
Extemporaneously compounded products are designed for an individual patient based on a licensed physician's prescription in response to an identified need. Compounding provides …
RHP II, LD Ashworth, R Löbenberg, S Benavides… - 2022 - researchgate.net
The purpose of this work was to evaluate the suitability of recent US Food and Drug Administration (USFDA) approved and marketed oral liquid, powder, or granule products for …